Picard Medical is trading 10.13% up now at $4.95 after opening-session volatility, with no confirmed company-specific catalyst identified for September 4, 2026.
- The latest major company release was its August 19 second-quarter report.
- An investor-investigation notice remains listed among recent headlines but predates today’s move.
- Broader markets are slightly lower, so the gain does not clearly track overall market direction.